Preimplantation genetic diagnosis (PGD) is performed among couples that have a higher risk of transmitting a genetic condition to their offspring. The technique is employed in in-vitro fertilization centers globally to select the euploid embryos to transfer and improve the clinical outcome of the clinical pregnancy, embryo implantation, and live birth rates. The ability to identify the...
The global preimplantation genetic testing (PGT) market was estimated to be valued at USD 802.2 million in 2023, with projections indicating a compound annual growth rate (CAGR) of 10.3% from 2024 to 2030. This growth is largely driven by the increasing prevalence of single-gene, mitochondrial, and other genetic disorders, which is anticipated to elevate the demand for preimplantation...
Preimplantation Genetic Testing Market Overview
According to the new report published by Straits Research, titled ""Preimplantation Genetic Testing Market Research Report: Global Opportunity Analysis and Industry Forecast, 2020 – 2026."" The aim of the report is to estimate the size of the Global Preimplantation Genetic Testing Market and the growth potential across different...
insightSLICE.com announces the release of the report "The Global Preimplantation Genetic Testing Market Research Report"- Size, Share, SWOT Analysis and Forecast 2023-2032.
Market Bits of knowledge:
The report gives market estimating and measure across five huge financial norms - USD, EUR GBP, JPY, and AUD. It helps tie-up originators make better decisions when money exchange data is...
The global preimplantation genetic testing market was estimated to be valued at USD 802.2 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2030. The increasing prevalence of single-gene, mitochondrial, and other genetic disorders is expected to drive the demand for preimplantation diagnosis and screening processes in the coming...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian